IL6 and neoplasm: Low CD90 expression in mesenchymal stromal cells has been linked to increased IL‐6 secretion, EMT induction, and chemoresistance in glioblastoma [80], as well as contributing to tumor vascularization and immunosuppression due to their higher production of VEGF and PGE2 [81].